Evaluation of spectrum of peripheral neuropathy in predialysis patients with chronic kidney disease

Renal Failure

Volumn 35, Issue 10, 2013, Pages 1323-1329

  Aggarwal, Hari K ^a   Sood, Sushma ^a   Jain, Deepak ^a   Kaverappa, Vipin ^a   Yadav, Sachin ^a  

^a PT B D SHARMA UNIVERSITY OF HEALTH SCIENCES   (India)

Author keywords

Chronic kidney disease; Nerve conduction velocity; Peripheral neuropathy

Indexed keywords

CREATININE; UREA;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIAN NERVE; MEDICAL EXAMINATION; MEDICAL HISTORY; MOTOR NERVE CONDUCTION; PERIPHERAL NEUROPATHY; PERONEUS NERVE; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM ASSESSMENT; TIBIAL NERVE; ULNAR NERVE; UREA BLOOD LEVEL; UREMIC POLYNEUROPATHY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84885946814     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.828261     Document Type: Article

References (26)

1. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Altered motor nerve excitability in end-stage kidney disease. Brain. 2005;128:2164-2174
2. Laaksonen S, Metsarinne K, Voipio-Pulkki LM, Falck B. Neurophysiologic parameters and symptoms in chronic renal failure. Muscle Nerve. 2002;25:884-890
3. Tilki HE, Akpolat T, Coskun M, Stalberg E. Clinical and electrophysiologic findings in dialysis patients. J Electromyogr Kinesiol. 2009;19(3):500-508
4. Brouns R, De Deyn PP. Neurological complications in renal failure: A review. Clin Neurol Neurosurg. 2004;107:1-16
5. Ogura T, Makinodan A, Kubo T, Hayashida T, Hirasawa Y. Electrophysiological course of uraemic neuropathy in hemodialysis patients. Postgrad Med J. 2001;77(909):451-454
6. Bolton CF, Baltzan MA, Baltzan RB. Effects of renal transplantation on uremic neuropathy. A clinical and electrophysiologic study. N Engl J Med. 1971;284:1170-1175
7. Bolton CF. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology. 1976;26(2): 152-161
8. Bolton CF. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci. 1980;7:89-96
9. Asbury AK. Neuropathies with chronic renal failure, hepatic disorders, chronic respiratory insufficiency, and critical illness. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993:1251-1265
10. Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann Neurol. 1980;8:590-596
11. Dyck PJ. Detection, characterization, and staging of polyneuropathy: Assessed in diabetics. Muscle Nerve. 1988;11:21-32
12. Asbury AK, Victor M, Adams RD. Uremic polyneuropathy. Arch Neurol Psychiatr. 1963;8:413-428
13. Babb AL, Popovich RP, Christopher TG, Scribner BH. The genesis of the square meter-hour hypothesis. Trans Am Soc Artif Intern Organs. 1971;17:81-91
14. Vanholder R, De Smet R, Hsu C, Vogeleere P, Ringoir S. Uremic toxicity: The middle molecule hypothesis revisited. Semin Nephrol. 1994;14:205-218
15. Furst P, Zimmerman L, Bergstrom J. Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol. 1976;3:178-188
16. Man NK, Granger A, Rondon-Nucete M, et al. One year follow-up of short dialysis with a membrane highly permeable to middle molecules. Proc Eur Dial Transplant Assoc. 1973;10:236-246
17. Bostock H, Walters RJ, Andersen KV, Murray NM, Taube D, Kiernan MC. Has potassium been prematurely discarded as a contributing factor to the development of uraemic neuropathy? Nephrol Dial Transplant. 2004;19:1054-1057
18. Rakowski RF, Gadsby DC, De Weer P. Stoichiometry and voltage dependence of the sodium pump in voltage clamped, internally dialyzed squid giant axon. J Gen Physiol. 1989;93:903-941
19. Nielsen VK. The peripheral nerve function in chronic renal failure. V. Sensory and motor conduction velocity. Acta Med Scand. 1973; 194:445-454
20. Bostock H, Burke D, Hales JP. Differences in behavior of sensory and motor axons following release of ischemia. Brain. 1994;117: 225-234
21. Kiernan MC, Bostock H. Effects of membrane polarization and ischemia on the excitability properties of human motor axons. Brain. 2000;123:2542-2551
22. Krishnan AV, Pussell BA, Kiernan MC. Neuromuscular disease in the dialysis patient: An update for the nephrologist. Semin Dial. 2009;22(3):267-278
23. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Kiernan MC. Sensory nerve excitability and neuropathy in end stage kidney disease. J Neurol Neuro Surg Psychiatry. 2006; 77(4):548-551
24. Krishnan AV, Colebatch JG, Kiernan MC. Hypokalemia induces activity-dependent conduction block. Neurology. 2005; 65:1309-1312
25. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Neuropathy, axonal Na/K pump function and activitydependent excitability changes in endstage kidney disease. Clin Neurophysiol. 2006;117:992-997
26. Makkar RK, Kochar DK. Somatosensory evoked potentials (SSEPs); sensory nerve conduction velocity (SNCV) and motor nerve conduction velocity (MNCV) in chronic renal failure. Electromyogr Clin Neurophysiol. 1994;34(5):295-300